This Eric Merola film is about the story of the 40-year Laetrile cover-up, which is being made available for free viewing by the producers through October 24th.
The film was directed by Eric Merola, who directed the two brilliant films about the intrepid Dr. Stanislaw Burzynski, who discovered a cure for some cancers and has spent decades fighting the Federal government and the State government if Texas, who have legally besieged him over his medical breakthroughs for decades, without success.
‘Second Opinion’ is about the work of Dr. Kanematsu Sugiura, who spent most of his career at Memorial Sloan Kettering Cancer Center and one of the top cancer researchers of the 1970s.
Dr. Sugiura discovered that Laetrile, derived from apricot pits, had very positive effects in preventing the spread of malignant lung tumors in laboratory mice.
In control groups, which received only plain saline, the lung tumors spread in 80 to 90 percent of the animals. But in those given Laetrile, the tumors spread in only 10 to 20 percent…
Soon after these findings, a cover-up began, causing a Sloan-Kettering Public Relations official, Ralph Moss to follow his conscience and hold a press conference about the active suppression of Dr. Sugiura’s studies, costing him his job, naturally.
According to Moss: “The individuals on Sloan Kettering’s Board of Directors were a ‘Who’s Who’ of investors in petrochemical and other polluting industries. In other words, the hospital was being run by people who made their wealth by investing in the worst cancer-causing things on the planet.”
Quoting from Dr. Joseph Mercola, whose site, Mercola.com is hosting this film (and selling my company’s DVD, ‘The Grounded 2′):
“The Board was dominated by CEOs from top pharmaceutical companies that produce cancer drugs, whose interest was in promoting chemotherapy and undermining natural therapies. For example, both the Chairman and Vice President of Bristol-Myers Squibb (the world’s leading manufacturer of chemotherapy drugs) occupied high positions on the Board. Of the nine members of the hospital’s powerful Institutional Policy Committee, seven had ties to the pharmaceutical industry. Even the hospital itself invested in stock of these drug
companies. The Board also included directors of the biggest tobacco companies in the US – Phillip Morris and RJR Nabisco.
“If a cure for cancer were to be found in an extract from the lowly apricot seed, it would be a terrible economic blow to the cancer-drug industry,” and as William W. Vodra, the former Associate Chief Counsel for Drugs at the FDA said: “Nobody is going to pay
$70,000 for a new cancer drug if they can buy Laetrile for 75 cents.”
It is plain that Sloan Kettering’s Board realized that Laetrile offered no hope, as a profitable cancer treatment – so it was squashed. Although new studies continue to support Dr. Sugiura’s findings, they have yet to issue an apology to him and the millions of people who have lost loved ones to lung cancer (including me) but you
can ask them to do so, by signing here.
As Dr. Mercola says, the cancer industry “is based on toxic drugs, dangerous surgeries, and expensive machines. There’s an enormous amount of money to be made in this system, and those who threaten to overturn it will pay a steep price…
“We continue to see one case after another of shocking medical science fraud, particularly in the extremely profitable cancer industry.
“Our current medical system has been masterfully orchestrated by the drug companies to create a system that gives the perception of science-based medicine when it is really a heavily manipulated process designed to boost their profits, and more accurately labeled science-biased medicine.” [Emphases mine – AB].
From Dr. Mercola:
Contemporary Laetrile Studies Confirm Sugiura’s Work â€” But an Apology from Sloan Kettering Is Nowhere to Be Found
The research into Laetrile did not stop just because Sloan Kettering buried it 40 years ago. Many recent studies confirm Dr. Sugiura’s work, supporting his conclusion that Laetrile shows potential in reducing the spread of cancer, although it’s not a cure. Laetrile and amygdalin may also have benefits for other medical issues, such as kidney disease. Here are just a few of the more recent studies that substantiate Dr. Sugiura’s work:
* August 2014: In a new German study, amygdalin dose-dependently reduced growth and proliferation of bladder cancer
* May 2013: Amygdalin inhibits renal fibrosis in chronic kidney disease; researchers conclude it is a â€œpotent antifibrotic agent that may have therapeutic potential for patients with fibrotic kidney diseasesâ€
* February 2013: Amygdalin induces apoptosis in human cervical cancer cells; authors conclude it may offer a new therapeutic option for cervical cancer patients.
* August 2006: Amygdalin also induces apoptosis in human prostate cancer cells.
* February 2003: Amygdalin from Prunus persica seeds (peach pits) shows anti-tumor effects comparable to epigallocatechin gallate in green tea.
Despite contemporary research findings, you will find no retraction (or apology) by Sloan Kettering, and sadly, the vast majority of cancer information sites claim that Laetrile is useless as a cancer treatment. Laetrile was a lost opportunity. This type of misinformation is rampant in the industry, and the people who really suffer are those battling cancer and denied access to treatments that could potentially save them or extend their lives. The facts show that Dr. Sugiura was both competent and honest, but instead of accolades, he received nothing but grief because he just happened to step into the middle of a political hornets’ nest.
Sign the Petition Now!
Ralph Moss’s organization Second Opinion has a petition urging Memorial Sloan Kettering Cancer Center to acknowledge its positive results about Laetrile from the 1970s. You can sign that petition here:
Since being fired by Sloan Kettering in 1975, Ralph Moss has written or edited 12 books and three film documentaries about issues related to cancer research and treatment. He currently directs The Moss Reports, an up-to-date library of detailed reports on more than 200 types of cancer. You can obtain further information about Dr. Moss and his work on his website: